A Systematic Review and Meta-Analysis of Cerebrospinal Fluid Amyloid and Tau Levels Identifies Mild Cognitive Impairment Patients Progressing to Alzheimer’s Disease

Performance of plasma phosphorylated tau 181 and 217 in the community

(2022) Michelle M. Mielke et al.   NATURE MEDICINE

Development of Alzheimer’s Disease Biomarkers: From CSF- to Blood-Based Biomarkers

(2022) Sakulrat Mankhong et al.   Biomedicines

The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

(2021) Matthew J Page et al.   BMJ-British Medical Journal

Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study

(2021) Elisabeth H Thijssen et al.   LANCET NEUROLOGY

CSF p-tau/Aβ42 ratio and brain FDG-PET may reliably detect MCI “imminent” converters to AD

(2020) Roberto Santangelo et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Improved Differential Diagnosis of Alzheimer’s Disease by Integrating ELISA and Mass Spectrometry-Based Cerebrospinal Fluid Biomarkers

(2019) Payam Emami Khoonsari et al.   JOURNAL OF ALZHEIMERS DISEASE

Combined Biomarker Prognosis of Mild Cognitive Impairment: An 11-Year Follow-Up Study in the Alzheimer’s Disease Neuroimaging Initiative

(2019) Barbara E. Spencer et al.   JOURNAL OF ALZHEIMERS DISEASE

Characteristic Biomarker and Cognitive Profile in Incipient Mixed Dementia

(2019) Carl Eckerström et al.   JOURNAL OF ALZHEIMERS DISEASE

Progression to dementia in memory clinic patients with mild cognitive impairment and normal β-amyloid

(2019) Anna Rosenberg et al.   Alzheimers Research & Therapy

Aging and Alzheimer’s disease: Comparison and associations from molecular to system level

(2018) Xian Xia et al.   AGING CELL

Addition of the Aβ42/40 ratio to the cerebrospinal fluid biomarker profile increases the predictive value for underlying Alzheimer’s disease dementia in mild cognitive impairment

(2018) Inês Baldeiras et al.   Alzheimers Research & Therapy

Longitudinal Changes of CSF Biomarkers in Alzheimer's Disease

(2018) Toni T. Seppälä et al.   JOURNAL OF ALZHEIMERS DISEASE

Performance of Aβ1-40, Aβ1-42, Total Tau, and Phosphorylated Tau as Predictors of Dementia in a Cohort of Patients with Mild Cognitive Impairment

(2018) Lucilla Parnetti et al.   JOURNAL OF ALZHEIMERS DISEASE

Current state of Alzheimer’s fluid biomarkers

(2018) José Luis Molinuevo et al.   ACTA NEUROPATHOLOGICA

Drugs in Clinical Trials for Alzheimer's Disease: The Major Trends

(2017) Sergey O. Bachurin et al.   MEDICINAL RESEARCH REVIEWS

Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry

(2017) Piotr Lewczuk et al.   WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY

Evaluation of CSF Biomarkers as Predictors of Alzheimer's Disease: A Clinical Follow-Up Study of 4.7 Years

(2017) Joakim Hertze et al.   JOURNAL OF ALZHEIMERS DISEASE

CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis

(2016) Bob Olsson et al.   LANCET NEUROLOGY

Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range

(2016) Dehui Luo et al.   STATISTICAL METHODS IN MEDICAL RESEARCH

Cerebrospinal fluid tau and amyloid-β1-42in patients with dementia

(2015) Tobias Skillbäck et al.   BRAIN

The relationship between iron dyshomeostasis and amyloidogenesis in Alzheimer's disease: Two sides of the same coin

(2015) Douglas G. Peters et al.   NEUROBIOLOGY OF DISEASE

The age factor in Alzheimer’s disease

(2015) Rita Guerreiro et al.   Genome Medicine

Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range

(2015) Xiang Wan et al.   BMC Medical Research Methodology

A critique of the drug discovery and phase 3 clinical programs targeting the amyloid hypothesis for Alzheimer disease

(2014) Eric Karran et al.   ANNALS OF NEUROLOGY

Cognitive screening for dementia in primary care: a systematic review

(2014) Juliana Emy Yokomizo et al.   INTERNATIONAL PSYCHOGERIATRICS

The association between biomarkers in cerebrospinal fluid and structural changes in the brain in patients with Alzheimer's disease

(2013) X. Li et al.   JOURNAL OF INTERNAL MEDICINE

Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers

(2013) Clifford R Jack et al.   LANCET NEUROLOGY

Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease

(2013) A. Prestia et al.   NEUROLOGY

Alzheimer disease in the United States (2010-2050) estimated using the 2010 census

(2013) L. E. Hebert et al.   NEUROLOGY

Cerebrospinal Fluid Levels ofβ-Amyloid 1-42, but Not of Tau, Are Fully Changed Already 5 to 10 Years Before the Onset of Alzheimer Dementia

(2012) Peder Buchhave   ARCHIVES OF GENERAL PSYCHIATRY

Preclinical Alzheimer disease—the challenges ahead

(2012) Reisa A. Sperling et al.   Nature Reviews Neurology

CSF biomarkers for Alzheimer disease correlate with cortical brain biopsy findings

(2012) T. T. Seppala et al.   NEUROLOGY

Comparison of Brief Cognitive Tests and CSF Biomarkers in Predicting Alzheimer’s Disease in Mild Cognitive Impairment: Six-Year Follow-Up Study

(2012) Sebastian Palmqvist et al.   PLoS One

Combination of Hippocampal Volume and Cerebrospinal Fluid Biomarkers Improves Predictive Value in Mild Cognitive Impairment

(2011) C. Eckerström et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

A Guide to Understanding Meta-analysis

(2011) Heidi Israel et al.   JOURNAL OF ORTHOPAEDIC & SPORTS PHYSICAL THERAPY

CSF tau markers are correlated with hippocampal volume in Alzheimer's disease

(2011) Leonardo C. de Souza et al.   NEUROBIOLOGY OF AGING

Mild Cognitive Impairment

(2011) Ronald C. Petersen   NEW ENGLAND JOURNAL OF MEDICINE

Identification of Conversion from Mild Cognitive Impairment to Alzheimer's Disease Using Multivariate Predictors

(2011) Yue Cui et al.   PLoS One

Cerebrospinal Fluid Biomarkers and Prediction of Conversion in Patients with Mild Cognitive Impairment: 4-Year Follow-Up in a Routine Clinical Setting

(2011) Alessia Lanari et al.   TheScientificWorldJOURNAL

The pathological process underlying Alzheimer’s disease in individuals under thirty

(2010) Heiko Braak et al.   ACTA NEUROPATHOLOGICA

Tau in Alzheimer Disease and Related Tauopathies

(2010) K. Iqbal et al.   Current Alzheimer Research

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

(2010) Kaj Blennow et al.   Nature Reviews Neurology

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

(2009) Leslie M. Shaw et al.   ANNALS OF NEUROLOGY

Subcortical Vascular Dementia Biomarker Pattern in Mild Cognitive Impairment

(2009) Maria Bjerke et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Progression of Mild Cognitive Impairment to Alzheimer’s Disease: Improved Diagnostic Value of the Combined Use of N200 Latency and β-Amyloid(1–42) Levels

(2009) V.T. Papaliagkas et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Cerebrospinal fluid total tau as a marker of Alzheimer's disease intensity

(2009) Kajsa Sämgård et al.   INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY

CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment

(2009) Niklas Mattsson   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Progression from MCI to AD: Predictive value of CSF Aβ42 is modified by APOE genotype

(2009) Maartje I. Kester et al.   NEUROBIOLOGY OF AGING

Endpoints for trials in Alzheimer's disease: a European task force consensus

(2008) Bruno Vellas et al.   LANCET NEUROLOGY

Multiplexed quantification of dementia biomarkers in the CSF of patients with early dementias and MCI: A multicenter study

(2007) Piotr Lewczuk et al.   NEUROBIOLOGY OF AGING

Prediction and longitudinal study of CSF biomarkers in mild cognitive impairment

(2007) Miroslaw Brys et al.   NEUROBIOLOGY OF AGING